Your browser doesn't support javascript.
loading
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.
Takuva, Simbarashe; Takalani, Azwidhwi; Seocharan, Ishen; Yende-Zuma, Nonhlanhla; Reddy, Tarylee; Engelbrecht, Imke; Faesen, Mark; Khuto, Kentse; Whyte, Carmen; Bailey, Veronique; Trivella, Valentina; Peter, Jonathan; Opie, Jessica; Louw, Vernon; Rowji, Pradeep; Jacobson, Barry; Groenewald, Pamela; Dorrington, Rob E; Laubscher, Ria; Bradshaw, Debbie; Moultrie, Harry; Fairall, Lara; Sanne, Ian; Gail-Bekker, Linda; Gray, Glenda; Goga, Ameena; Garrett, Nigel.
Afiliação
  • Takuva S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Takalani A; School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
  • Seocharan I; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Yende-Zuma N; Department of Family Medicine and Primary Care, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Reddy T; South African Medical Research Council, Durban, South Africa.
  • Engelbrecht I; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • Faesen M; South African Medical Research Council, Durban, South Africa.
  • Khuto K; Right to Care, Johannesburg, South Africa.
  • Whyte C; Right to Care, Johannesburg, South Africa.
  • Bailey V; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Trivella V; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Peter J; School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
  • Opie J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Louw V; Right to Care, Johannesburg, South Africa.
  • Rowji P; Division of Allergy and Clinical Immunology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Jacobson B; Division of Haematology, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.
  • Groenewald P; Division of Clinical Haematology, Department of Medicine, Faculty of Health Sciences, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
  • Dorrington RE; Milpark Hospital, Johannesburg, South Africa.
  • Laubscher R; Department of Molecular Medicine and Haematology, Charlotte Maxeke Johannesburg Academic Hospital National Health Laboratory System Complex and University of the Witwatersrand, Johannesburg, South Africa.
  • Bradshaw D; Burden of Disease Research Unit, South African Medical Research Council, Cape Town, South Africa.
  • Moultrie H; Centre for Actuarial Research, Faculty of Commerce, University of Cape Town, Cape Town, South Africa.
  • Fairall L; South African Medical Research Council, Durban, South Africa.
  • Sanne I; Burden of Disease Research Unit, South African Medical Research Council, Cape Town, South Africa.
  • Gail-Bekker L; National Institute for Communicable Diseases, National Health Laboratory Service, Sandringham, South Africa.
  • Gray G; Knowledge Translation Unit, University of Cape Town Lung Institute, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Goga A; King's Global Health Institute, King's College London, London, United Kingdom.
  • Garrett N; Right to Care, Johannesburg, South Africa.
PLoS Med ; 19(6): e1004024, 2022 06.
Article em En | MEDLINE | ID: mdl-35727802

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Evaluation_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Evaluation_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos